Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry

Sci Rep. 2022 Sep 6;12(1):15109. doi: 10.1038/s41598-022-19488-8.

Abstract

Glycosylation is an important attribute of monoclonal antibodies (mAbs) for assessing manufacturing quality. Analysis of non-human glycans containing terminal galactose-α1,3-galactose and N-glycolylneuraminic acid is essential due to the potential immunogenicity and insufficient efficacy caused by mAb expression in non-human mammalian cells. Using parallel sequencing of isobaric glycopeptides and isomeric glycans that were separated by reversed-phase and porous graphitic carbon LC, we report a highly sensitive LC MS/MS method for the comprehensive characterization of low-abundance non-human glycans and their closely related structural isomers. We demonstrate that the straightforward use of high-abundance diagnostic ions and complementary fragments under the positive ionization low-energy collision-induced dissociation is a universal approach to rapidly discriminate branch-linkage structures of biantennary glycans. Our findings reveal the structural diversity of non-human glycans and sulfation of α-galactosylated glycans, providing both an analytical method and candidate structures that could potentially be used in the crucial quality control of therapeutic mAb products.

MeSH terms

  • Animals
  • Antibodies, Monoclonal* / chemistry
  • Chromatography, Liquid / methods
  • Galactose / chemistry
  • Mammals
  • Polysaccharides / chemistry
  • Tandem Mass Spectrometry* / methods

Substances

  • Antibodies, Monoclonal
  • Polysaccharides
  • Galactose